(3R,4S)-1-benzyl-N,4-di-methylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 35 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Buy 2101958-24-9 Purchase 2101958-24-9 Order 2101958-24-9 Enquire 2101958-24-9 2101958-24-9 price 2101958-24-9 supplier 2101958-24-9 manufacturer 2101958-24-9 exporter Tofacitinib Impurity 35 for method validation Tofacitinib Impurity 35 reference standard Tofacitinib Impurity 35 for ANDA filing Tofacitinib Impurity 35 for forced degradation studies Tofacitinib Impurity 35 identification standard Tofacitinib Impurity 35 for DMF filing Tofacitinib Impurity 35 HPLC standard Tofacitinib Impurity 35 supplier Tofacitinib Impurity 35 manufacturer Tofacitinib Impurity 35 distributor
